Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Overview
Stock Information
Nasdaq:
COCPPrice

Change

Mkt Cap

Volume

52 week Low/High

Day Low/High
